GILEAD SCIENCES INC (1GILD.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1GILD - US3755581036 - Common Stock
103.52 EUR
-2.36 (-2.23%)
Taking everything into account, 1GILD scores 6 out of 10 in our fundamental rating. 1GILD was compared to 83 industry peers in the Biotechnology industry. While 1GILD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on 1GILD. 1GILD also has an excellent dividend rating. With these ratings, 1GILD could be worth investigating further for value and dividend investing!.
1. Profitability
1.1 Basic Checks
- 1GILD had positive earnings in the past year.
- In the past year 1GILD had a positive cash flow from operations.
- 1GILD had positive earnings in each of the past 5 years.
- Each year in the past 5 years 1GILD had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 13.86%, 1GILD belongs to the top of the industry, outperforming 86.75% of the companies in the same industry.
- 1GILD has a Return On Equity of 37.80%. This is amongst the best in the industry. 1GILD outperforms 97.59% of its industry peers.
- 1GILD has a Return On Invested Capital of 18.54%. This is amongst the best in the industry. 1GILD outperforms 95.18% of its industry peers.
- 1GILD had an Average Return On Invested Capital over the past 3 years of 16.22%. This is above the industry average of 12.74%.
- The last Return On Invested Capital (18.54%) for 1GILD is above the 3 year average (16.22%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.86% | ||
| ROE | 37.8% | ||
| ROIC | 18.54% |
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
1.3 Margins
- With an excellent Profit Margin value of 27.88%, 1GILD belongs to the best of the industry, outperforming 85.54% of the companies in the same industry.
- 1GILD's Profit Margin has declined in the last couple of years.
- 1GILD has a Operating Margin of 38.96%. This is amongst the best in the industry. 1GILD outperforms 95.18% of its industry peers.
- 1GILD's Operating Margin has improved in the last couple of years.
- 1GILD's Gross Margin of 78.72% is fine compared to the rest of the industry. 1GILD outperforms 67.47% of its industry peers.
- In the last couple of years the Gross Margin of 1GILD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.96% | ||
| PM (TTM) | 27.88% | ||
| GM | 78.72% |
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1GILD is creating value.
- 1GILD has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for 1GILD has been reduced compared to 5 years ago.
- Compared to 1 year ago, 1GILD has a worse debt to assets ratio.
2.2 Solvency
- There is no outstanding debt for 1GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC2.28
WACC8.14%
2.3 Liquidity
- 1GILD has a Current Ratio of 1.53. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
- 1GILD has a worse Current ratio (1.53) than 61.45% of its industry peers.
- 1GILD has a Quick Ratio of 1.17. This is a normal value and indicates that 1GILD is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.17, 1GILD is doing worse than 65.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
- 1GILD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.88%, which is quite impressive.
- 1GILD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.01% yearly.
- The Revenue has been growing slightly by 2.78% in the past year.
- The Revenue has been growing slightly by 5.08% on average over the past years.
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
3.2 Future
- Based on estimates for the next years, 1GILD will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.55% on average per year.
- 1GILD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.01% yearly.
EPS Next Y80.6%
EPS Next 2Y38.7%
EPS Next 3Y27.13%
EPS Next 5Y19.55%
Revenue Next Year3.16%
Revenue Next 2Y3.13%
Revenue Next 3Y3.74%
Revenue Next 5Y4.01%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 14.89 indicates a correct valuation of 1GILD.
- 1GILD's Price/Earnings ratio is rather cheap when compared to the industry. 1GILD is cheaper than 87.95% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.54. 1GILD is valued slightly cheaper when compared to this.
- The Price/Forward Earnings ratio is 13.76, which indicates a correct valuation of 1GILD.
- 1GILD's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1GILD is cheaper than 93.98% of the companies in the same industry.
- 1GILD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.31, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.89 | ||
| Fwd PE | 13.76 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1GILD is valued cheaper than 85.54% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, 1GILD is valued cheaper than 87.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.9 | ||
| EV/EBITDA | 10.07 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- 1GILD has an outstanding profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as 1GILD's earnings are expected to grow with 27.13% in the coming years.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y38.7%
EPS Next 3Y27.13%
5. Dividend
5.1 Amount
- 1GILD has a Yearly Dividend Yield of 2.51%. Purely for dividend investing, there may be better candidates out there.
- 1GILD's Dividend Yield is rather good when compared to the industry average which is at 0.76. 1GILD pays more dividend than 95.18% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.92, 1GILD pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.51% |
5.2 History
- The dividend of 1GILD has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
- 1GILD pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
- 1GILD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP12%
EPS Next 2Y38.7%
EPS Next 3Y27.13%
BIT:1GILD (12/18/2025, 7:00:00 PM)
103.52
-2.36 (-2.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-09 2026-02-09/amc
Inst Owners91.32%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap128.44B
Revenue(TTM)29.09B
Net Income(TTM)8.11B
Analysts81.08
Price Target110.22 (6.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.51% |
Yearly Dividend2.67
Dividend Growth(5Y)4.45%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)-1.8%
PT rev (3m)0.94%
EPS NQ rev (1m)-10.1%
EPS NQ rev (3m)-12.46%
EPS NY rev (1m)1.61%
EPS NY rev (3m)0.79%
Revenue NQ rev (1m)0.28%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)1.35%
Revenue NY rev (3m)1.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.89 | ||
| Fwd PE | 13.76 | ||
| P/S | 5.2 | ||
| P/FCF | 15.9 | ||
| P/OCF | 15.66 | ||
| P/B | 7.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.07 |
EPS(TTM)6.95
EY6.71%
EPS(NY)7.52
Fwd EY7.27%
FCF(TTM)6.51
FCFY6.29%
OCF(TTM)6.61
OCFY6.39%
SpS19.89
BVpS14.67
TBVpS-3.3
PEG (NY)0.18
PEG (5Y)N/A
Graham Number47.9
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.86% | ||
| ROE | 37.8% | ||
| ROCE | 24.51% | ||
| ROIC | 18.54% | ||
| ROICexc | 23.24% | ||
| ROICexgc | 80.87% | ||
| OM | 38.96% | ||
| PM (TTM) | 27.88% | ||
| GM | 78.72% | ||
| FCFM | 32.73% |
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 68.56% | ||
| Profit Quality | 117.39% | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | N/A |
F-Score7
WACC8.14%
ROIC/WACC2.28
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
EPS Next Y80.6%
EPS Next 2Y38.7%
EPS Next 3Y27.13%
EPS Next 5Y19.55%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
Revenue Next Year3.16%
Revenue Next 2Y3.13%
Revenue Next 3Y3.74%
Revenue Next 5Y4.01%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.48%
EBIT Next 3Y25.45%
EBIT Next 5Y19.13%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%
GILEAD SCIENCES INC / 1GILD.MI FAQ
What is the ChartMill fundamental rating of GILEAD SCIENCES INC (1GILD.MI) stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI.
What is the valuation status for 1GILD stock?
ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (1GILD.MI). This can be considered as Undervalued.
Can you provide the profitability details for GILEAD SCIENCES INC?
GILEAD SCIENCES INC (1GILD.MI) has a profitability rating of 8 / 10.
What are the PE and PB ratios of GILEAD SCIENCES INC (1GILD.MI) stock?
The Price/Earnings (PE) ratio for GILEAD SCIENCES INC (1GILD.MI) is 14.89 and the Price/Book (PB) ratio is 7.06.
What is the financial health of GILEAD SCIENCES INC (1GILD.MI) stock?
The financial health rating of GILEAD SCIENCES INC (1GILD.MI) is 5 / 10.